Journal
CELLULAR IMMUNOLOGY
Volume 329, Issue -, Pages 50-55Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2018.04.013
Keywords
Myeloid-derived suppressor cells; Bone marrow; Nonhuman primate; T cells; Immune regulation
Categories
Funding
- National Institutes of Health, part of the NIH NHP Transplantation Tolerance Cooperative Study Group [U01 AI 136779]
- NIAID
- NIDDK
Ask authors/readers for more resources
Putative monocytic myeloid-derived suppressor cells (mMDSC; lineage(-)HLA-DR-/lo) were generated in 7-day cultures from normal rhesus macaque bone marrow (BM) cells in GM-CSF and IL-6. Three subsets were identified based on their differential expression of CD14, CD33, CD34 and CD11b. Following flow sorting, assessment of the capacity of these subsets to suppress anti-CD3/CD28-stimulated CD4 and CD8 T cell proliferation revealed that the most potent population was CD14(hi)CD33(-/lo)CD34(lo)CD11b(hi). These BM-derived mMDSC markedly increased the incidence of CD4(+)CD25(+)CD127(-)Foxp3(+) regulatory T cells in responder T cell populations. They offer potential value in testing the therapeutic efficacy of immunoregulatory mMDSC for the promotion of tolerance in nonhuman primate transplant models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available